J. Goldman & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,500
| Closed | -$219K | – | 472 |
|
|
2024
Q2 | $219K | Sell |
13,500
-13,500
| -50% | -$219K | 0.01% | 282 |
|
|
2024
Q1 | $381K | Hold |
27,000
| – | – | 0.01% | 233 |
|
|
2023
Q4 | $282K | Hold |
27,000
| – | – | 0.01% | 181 |
|
|
2023
Q3 | $275K | Sell |
27,000
-715,500
| -96% | -$7.3M | 0.01% | 195 |
|
|
2023
Q2 | $5.59M | Buy |
+742,500
| New | +$5.59M | 0.2% | 86 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 274 |
|
|
2016
Q3 | – | Sell |
-11,500
| Closed | -$578K | – | 279 |
|
|
2016
Q2 | $578K | Sell |
11,500
-337,800
| -97% | -$17M | 0.03% | 156 |
|
|
2016
Q1 | $18.7M | Buy |
+349,300
| New | +$18.7M | 1.16% | 8 |
|
|
2015
Q3 | – | Sell |
-111,746
| Closed | -$6.6M | – | 231 |
|
|
2015
Q2 | $6.6M | Buy |
+111,746
| New | +$6.6M | 0.4% | 39 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 225 |
|